chrX-151403744-A-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001017980.4(VMA21):c.163+4A>G variant causes a splice donor region, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 24)
Consequence
VMA21
NM_001017980.4 splice_donor_region, intron
NM_001017980.4 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.9592
1
1
Clinical Significance
Conservation
PhyloP100: 5.07
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, max_spliceai. No scorers claiming Uncertain. Scorers claiming Benign: dbscSNV1_RF.
PP5
Variant X-151403744-A-G is Pathogenic according to our data. Variant chrX-151403744-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 208720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-151403744-A-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.163+4A>G | splice_donor_region_variant, intron_variant | ENST00000330374.7 | NP_001017980.1 | |||
VMA21 | NM_001363810.1 | c.328+4A>G | splice_donor_region_variant, intron_variant | NP_001350739.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.163+4A>G | splice_donor_region_variant, intron_variant | 1 | NM_001017980.4 | ENSP00000333255 | P1 | |||
VMA21 | ENST00000370361.5 | c.328+4A>G | splice_donor_region_variant, intron_variant | 5 | ENSP00000359386 | |||||
VMA21 | ENST00000477649.1 | n.243+4A>G | splice_donor_region_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 23
GnomAD4 exome
Cov.:
23
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked myopathy with excessive autophagy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. Experimental studies have shown that this variant affects VMA21 function (PMID: 23315026). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 208720). This variant has been observed in individuals with X-linked myopathy with excessive autophagy (PMID: 23315026, 25809233). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 2 of the VMA21 gene. It does not directly change the encoded amino acid sequence of the VMA21 protein. It affects a nucleotide within the consensus splice site. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2013 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2014 | The c.163+4A>G intronic alteration consists of a A to G substitution nucleotides after coding exon 2 in the VMA21 gene. The alteration is not observed in healthy cohorts:_x000D_ _x000D_ Based on data from the NHLBI Exome Sequencing Project (ESP), the c.163+4A>G alteration was not observed among 6,503 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project and the alteration is not currently listed in the Database of Single Nucleotide Polymorphisms (dbSNP). Though some variants may appear to be rare due to database-specific ethnic underrepresentation, rare missense alleles commonly exhibit a deleterious effect on protein function (Kryukov, 2007; Tennessen, 2012). REFERENCES: Kryukov GV, et al. (2007) Am J Hum Genet 80:727-739. Tennessen JA, et al. (2012) Science 337(64):64-69. The altered nucleotide is conserved throughout evolution:_x000D_ _x000D_ This nucleotide position is highly conserved in available vertebrate species. Functional analysis reveals a damaging effect of the nucleotide alteration: _x000D_ _x000D_ (Ramachandran, 2013): "c.163+4A>G, removes the A in the +4 position after exon 2, which contributes to optimal U1 snRNA binding during splicing." Demonstration of RNA reduction by quantative RT-PCR and protein level reduction by Western (in vitro analyses included both pateint fibroblast and lymphoblasts as well as yeast complementation assay) The alteration is predicted deleterious by in silico models:_x000D_ _x000D_ The c.163+4A>G alteration is predicted to weaken the native splice donor site efficiency by the in silico programs Fruitfly and ESEfinder 3.0. Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -4
Find out detailed SpliceAI scores and Pangolin per-transcript scores at